» Articles » PMID: 23626725

Filter Characteristics Influencing Circulating Tumor Cell Enrichment from Whole Blood

Overview
Journal PLoS One
Date 2013 Apr 30
PMID 23626725
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

A variety of filters assays have been described to enrich circulating tumor cells (CTC) based on differences in physical characteristics of blood cells and CTC. In this study we evaluate different filter types to derive the properties of the ideal filter for CTC enrichment. Between 0.1 and 10 mL of whole blood spiked with cells from tumor cell lines were passed through silicon nitride microsieves, polymer track-etched filters and metal TEM grids with various pore sizes. The recovery and size of 9 different culture cell lines was determined and compared to the size of EpCAM+CK+CD45-DNA+ CTC from patients with metastatic breast, colorectal and prostate cancer. The 8 µm track-etched filter and the 5 µm microsieve had the best performance on MDA-231, PC3-9 and SKBR-3 cells, enriching >80% of cells from whole blood. TEM grids had poor recovery of ∼25%. Median diameter of cell lines ranged from 10.9-19.0 µm, compared to 13.1, 10.7, and 11.0 µm for breast, prostate and colorectal CTC, respectively. The 11.4 µm COLO-320 cell line had the lowest recovery of 17%. The ideal filter for CTC enrichment is constructed of a stiff, flat material, is inert to blood cells, has at least 100,000 regularly spaced 5 µm pores for 1 ml of blood with a ≤10% porosity. While cell size is an important factor in determining recovery, other factors must be involved as well. To evaluate a filtration procedure, cell lines with a median size of 11-13 µm should be used to challenge the system.

Citing Articles

Label-Free and Rapid Microfluidic Design Rules for Circulating Tumor Cell Enrichment and Isolation: A Review and Simulation Analysis.

Mansor M, Yang C, Chong K, Jamrus M, Liu K, Yu M ACS Omega. 2025; 10(7):6306-6322.

PMID: 40028152 PMC: 11866005. DOI: 10.1021/acsomega.4c08606.


Enhanced detection of circulating tumor cells using a MUC1 promoter-driven recombinant adenovirus.

Wang C, Gu H, Cai J, Zhu C, Zheng Q, Xu H Front Oncol. 2025; 14:1506968.

PMID: 39886667 PMC: 11779711. DOI: 10.3389/fonc.2024.1506968.


A label-free optical system with a nanohole array biosensor for discriminating live single cancer cells from normal cells.

Franco A, Vidal V, Gomez M, Gutierrez O, Martino M, Gonzalez F Nanophotonics. 2024; 11(2):315-328.

PMID: 39633886 PMC: 11501809. DOI: 10.1515/nanoph-2021-0499.


Label-Free Microfluidic Apheresis of Circulating Tumor Cell Clusters.

Zhan L, Edd J, Mishra A, Toner M Adv Sci (Weinh). 2024; 11(40):e2405853.

PMID: 39199012 PMC: 11515904. DOI: 10.1002/advs.202405853.


Palladium-103 (Pd/Rh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to Lu and Tb.

Hindie E, Larouze A, Alcocer-Avila M, Morgat C, Champion C Theranostics. 2024; 14(11):4318-4330.

PMID: 39113794 PMC: 11303077. DOI: 10.7150/thno.95436.


References
1.
Talasaz A, Powell A, Huber D, Berbee J, Roh K, Yu W . Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A. 2009; 106(10):3970-5. PMC: 2645911. DOI: 10.1073/pnas.0813188106. View

2.
Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

3.
Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K . Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol. 2000; 156(1):57-63. PMC: 1868645. DOI: 10.1016/S0002-9440(10)64706-2. View

4.
Hsieh H, Marrinucci D, Bethel K, Curry D, Humphrey M, Krivacic R . High speed detection of circulating tumor cells. Biosens Bioelectron. 2006; 21(10):1893-9. DOI: 10.1016/j.bios.2005.12.024. View

5.
Ligthart S, Bidard F, Decraene C, Bachelot T, Delaloge S, Brain E . Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer. Ann Oncol. 2013; 24(5):1231-8. DOI: 10.1093/annonc/mds625. View